Short Bowel Syndrome clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.
open to eligible people ages 18 years and up
The primary objective of the trial is to assess long-term safety and tolerability of apraglutide in subjects with SBS-IF.
at UCLA
Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF
Sorry, in progress, not accepting new patients
The primary objective of the trial is the confirmation of the efficacy of apraglutide to evaluate the efficacy of weekly subcutaneous apraglutide in reducing parenteral support dependency.
at UCLA
Last updated: